William Guyer, Chief Development Officer: Corcept Therapeutics CORT Sell · Filed 25/07/21

Trade details

Type: Insider sale
Amount: $321,768.92
Shares · price: 4,379 sh · $73.48 a share
Held after: 5,487 sh
Stock: Corcept Therapeutics CORT
Person: William GuyerChief Development Officer
Trade date: 25/07/17
Filed: 25/07/21
Days to filing: 4 days

Sold 44.4% of holdings

Share of holding sold: 44.4%

Corcept Therapeutics trades, last 26 weeks

What else happened in Corcept Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/17~25/08/16

William Guyer's recent trades

William GuyerChief Development Officer
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$2.3M
20,000 sh
$2.3M
Filed 08/04
Traded 08/04
William GuyerChief Development Officer
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.9M
20,000 sh
$1.9M
Filed 07/07
Traded 07/07
William GuyerChief Development Officer
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$1.4M
20,000 sh
$1.4M
Filed 06/04
Traded 06/02
William GuyerChief Development Officer
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.4M
20,000 sh
$1.4M
Filed 06/02
Traded 06/02
William GuyerChief Development Officer
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$1M
20,000 sh
$1M
Filed 05/07
Traded 05/05